Aptissen
Plan-les-ouates · Founded 2013
About Aptissen
Aptissen S.A. was founded in 2013 as a spin-off of ANTEIS, and is based in Geneva area, Switzerland. The company is specialized in the development, distribution, and commercialization of biopolymer-based medical devices (Synolis VA range) and food supplement (Cartylis) in the area of joint health. Aptissen’s team revolutionized the viscosupplement market with Synolis VA and its patented formulation which combines Hyaluronic Acid and Sorbitol. Synolis VA provides rapid mobility recovery, fast long-lasting pain relief associated with excellent safety. Aptissen distributes its products through a worldwide international distributors' network among more than 50 countries including Europe, South America, Canada, Middle East and Asia. It has subsidiaries in Italy, Poland & France and two license partners. Aptissen is 100% subcontracted and has 3 supply sources located in Europe, with a marging rate of 67%. The company has the following certifications: CE certified, ISO13485, MDSAP & GMP compliant, MDR ready.
Company Facts
- Founded: 2013
- Operating status: Operating
- Company type: For Profit
- IPO status: Private
- Employees: 11 – 50
- Estimated revenue: $10K – $50K
- Funding stage: Seed
- Last round: Seed (Jun 2014)
- Website: aptissen.com
- Phone: [email protected]
Social Profiles
Canonical: https://fsome.com/organization/aptissen-8261835 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.